author-photo

Greg Fulcher

Royal North Shore Hospital
University of Sydney

112

Papers

8476

Citations

Citation Trend

Filter By

Papers (112) Sort By

Journal Conference Others

Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS Program and CREDENCE trial.

2021 Cardiovascular Research
Show All
- Source
- Cite
- Save
Citations (1)
Author response for "Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis"

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA1c, disease duration and treatment intensity: results from the CANVAS Program

2021 Diabetologia
Show All
- Source
- Cite
- Save
Citations (0)
Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program

2021
Show All
- Source
- Cite
- Save
Citations (1)
Reasons for hospitalizations in patients with type 2 diabetes in the CANVAS programme: A secondary analysis

2021 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Author response for " SGLT2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes"

2020 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (0)
Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: a longitudinal study

2020 BMJ open diabetes research & care
Show All
- Source
- Cite
- Save
Citations (2)
SGLT2 inhibitors with and without metformin: a meta‐analysis of cardiovascular, kidney and mortality outcomes

2020 Diabetes, Obesity and Metabolism
Show All
- Source
- Cite
- Save
Citations (17)
The Clinical Role of Insulin Degludec/Insulin Aspart in Type 2 Diabetes: An Empirical Perspective from Experience in Australia.

2020 Journal of Clinical Medicine
Show All
- Source
- Cite
- Save
Citations (4)
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.

2020 American Journal of Kidney Diseases
Show All
- Source
- Cite
- Save
Citations (8)